Citrinin Derivatives From Penicillium Citrinum Y34 That Inhibit alpha-Glucosidase and ATP-Citrate Lyase
文献类型:期刊论文
作者 | Chen, Shanji4,5; Tian, Danmei4,5; Wei, Jihua3; Li, Cong2; Ma, Yihan3; Gou, Xiaoshuang4,5; Shen, Yiran2; Chen, Mei4,5; Zhang, Sihao4,5; Li, Jia1,2![]() |
刊名 | FRONTIERS IN MARINE SCIENCE
![]() |
出版日期 | 2022-07-22 |
卷号 | 9页码:11 |
关键词 | Penicillium citrinum Y34 citrinin dimer alpha-Glucosidase inhibitory activity ACL inhibitory activity molecular docking |
DOI | 10.3389/fmars.2022.961356 |
通讯作者 | Wu, Bin(wubin@zju.edu.cn) ; Tang, Jinshan(gztangjinshan@126.com) |
英文摘要 | Two new citrinin dimers bearing a 6,6-spiroketal moiety (1 and 2) and four known analogues (3-6), together with 18 known citrinin monomers (7-24), were isolated from the culture of hydrothermal vent-associated fungus Penicillium citrinum Y34. Their structures were identified by extensive spectroscopic analyses, C-13 NMR calculation in combination with DP4+, linear correlation coefficient (R-2), and mean absolute error (MAE) values analyses, and electronic circular dichroism (ECD) calculation. The alpha-glucosidase and ATP-citrate lyase (ACL) inhibitory activities of isolated compounds were evaluated. Compounds 1, 3, and 12 displayed moderate alpha-glucosidase inhibitory activities with IC50 values of 239.8, 176.2, and 424.4 mu M, respectively. Enzyme kinetics investigations of 1 and 3 suggested their non-competitive inhibition of alpha-glucosidase with K-i values of 204.3 and 212.7 mu M, respectively. Meanwhile, compound 4 showed significant ACL inhibitory potential with an IC50 value of 17.4 mu M. Furthermore, the interactions of 1, 3, and 12 with alpha-glucosidase and 4 with ACL were investigated by molecular docking assay. This study demonstrates that citrinins, especially for their dimers, could be potential lead compounds for the development of new agents for the treatment of metabolic diseases. |
WOS关键词 | ENDOPHYTIC FUNGUS ; MYCOTOXIN CITRININ ; POLYKETIDES ; METABOLITES ; ANTIOXIDANT |
资助项目 | National Key Research and Development Program of China[2018YFC0311002] ; Guangzhou Basic and Applied Basic Foundation[202201010305] ; National Nature Science Foundation of China[41876148] |
WOS研究方向 | Environmental Sciences & Ecology ; Marine & Freshwater Biology |
语种 | 英语 |
WOS记录号 | WOS:000837274300001 |
出版者 | FRONTIERS MEDIA SA |
源URL | [http://119.78.100.183/handle/2S10ELR8/301905] ![]() |
专题 | 新药研究国家重点实验室 |
通讯作者 | Wu, Bin; Tang, Jinshan |
作者单位 | 1.Pilot Natl Lab Marine Sci & Technol Qingdao, Open Studio Druggabil Res Marine Nat Prod, Qingdao, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai, Peoples R China 3.Zhejiang Univ, Ocean Coll, Hangzhou, Peoples R China 4.Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Peoples R China 5.Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Coll Pharm, Guangzhou, Peoples R China |
推荐引用方式 GB/T 7714 | Chen, Shanji,Tian, Danmei,Wei, Jihua,et al. Citrinin Derivatives From Penicillium Citrinum Y34 That Inhibit alpha-Glucosidase and ATP-Citrate Lyase[J]. FRONTIERS IN MARINE SCIENCE,2022,9:11. |
APA | Chen, Shanji.,Tian, Danmei.,Wei, Jihua.,Li, Cong.,Ma, Yihan.,...&Tang, Jinshan.(2022).Citrinin Derivatives From Penicillium Citrinum Y34 That Inhibit alpha-Glucosidase and ATP-Citrate Lyase.FRONTIERS IN MARINE SCIENCE,9,11. |
MLA | Chen, Shanji,et al."Citrinin Derivatives From Penicillium Citrinum Y34 That Inhibit alpha-Glucosidase and ATP-Citrate Lyase".FRONTIERS IN MARINE SCIENCE 9(2022):11. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。